10-Q Filing

ST JUDE MEDICAL INC CIK: 203077 Q2 2009

Filing Information

Form Type	10-Q
Accession Number	`0000950123-09-034092`
Period End Date	20090630
Filing Date	20090812
Fiscal Year	2009
Fiscal Period	Q2
XBRL Instance	stj-20090704.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 82 Income Statement 28 Cash Flow Statement 30

Balance Sheet 82 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$28.97M	USD	Point-in-time
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$30.94M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$486.57M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$136.44M	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $30,942 at July 4, 2009 and $28,971 at January 3, 2009	`AccountsReceivableNetCurrent`	$1.18B	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $30,942 at July 4, 2009 and $28,971 at January 3, 2009	`AccountsReceivableNetCurrent`	$1.10B	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Inventories	`InventoryNet`	$620.12M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Inventories	`InventoryNet`	$546.50M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Deferred income taxes, net	`DeferredTaxAssetsNetCurrent`	$137.04M	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxAssetsNetCurrent`	$135.45M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	345.33M	shares	Point-in-time
Other	`OtherAssetsCurrent`	$158.82M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	347.64M	shares	Point-in-time
Other	`OtherAssetsCurrent`	$204.61M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	345.33M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$2.08B	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	347.64M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$2.62B	USD	Point-in-time
Property, plant and equipment, at cost	`PropertyPlantAndEquipmentGross`	$1.68B	USD	Point-in-time
Property, plant and equipment, at cost	`PropertyPlantAndEquipmentGross`	$1.83B	USD	Point-in-time
Less: accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$695.80M	USD	Point-in-time
Less: accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$762.11M	USD	Point-in-time
Net property, plant and equipment	`PropertyPlantAndEquipmentNet`	$980.18M	USD	Point-in-time
Net property, plant and equipment	`PropertyPlantAndEquipmentNet`	$1.07B	USD	Point-in-time
Goodwill	`Goodwill`	$1.98B	USD	Point-in-time
Goodwill	`Goodwill`	$1.99B	USD	Point-in-time
Other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$493.54M	USD	Point-in-time
Other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$474.26M	USD	Point-in-time
Other	`OtherAssetsNoncurrent`	$184.16M	USD	Point-in-time
Other	`OtherAssetsNoncurrent`	$208.45M	USD	Point-in-time
Total other assets	`TotalOtherAssets`	$2.67B	USD	Point-in-time
Total other assets	`TotalOtherAssets`	$2.66B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$5.72B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$6.36B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$324.52M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$75.52M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$238.31M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$229.24M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$18.36M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$17.61M	USD	Point-in-time
Employee compensation and related benefits	`EmployeeRelatedLiabilitiesCurrent`	$284.38M	USD	Point-in-time
Employee compensation and related benefits	`EmployeeRelatedLiabilitiesCurrent`	$297.29M	USD	Point-in-time
Other	`OtherLiabilitiesCurrent`	$399.80M	USD	Point-in-time
Other	`OtherLiabilitiesCurrent`	$386.82M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.24B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.03B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$961.02M	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$1.13B	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxLiabilitiesNoncurrent`	$126.74M	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxLiabilitiesNoncurrent`	$112.23M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$219.76M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$254.39M	USD	Point-in-time
Total liabilities	`Liabilities`	$2.59B	USD	Point-in-time
Total liabilities	`Liabilities`	$2.49B	USD	Point-in-time
Preferred stock ($1.00 par value; 25,000,000 shares authorized; none outstanding)	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock ($1.00 par value; 25,000,000 shares authorized; none outstanding)	`PreferredStockValue`	-	USD	Point-in-time
Common stock ($0.10 par value; 500,000,000 shares authorized; 347,640,007 and 345,332,272 shares issued and outstanding at July 4, 2009 and January 3, 2009, respectively)	`CommonStockValue`	$34.53M	USD	Point-in-time
Common stock ($0.10 par value; 500,000,000 shares authorized; 347,640,007 and 345,332,272 shares issued and outstanding at July 4, 2009 and January 3, 2009, respectively)	`CommonStockValue`	$34.76M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$219.04M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$302.68M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$2.98B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$3.40B	USD	Point-in-time
Cumulative translation adjustment	`AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax`	$-1.02M	USD	Point-in-time
Cumulative translation adjustment	`AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax`	$35.96M	USD	Point-in-time
Unrealized gain on available-for-sale securities	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$6.14M	USD	Point-in-time
Unrealized gain on available-for-sale securities	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$6.69M	USD	Point-in-time
Unrealized loss on derivative financial instruments	`AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax`	-	USD	Point-in-time
Unrealized loss on derivative financial instruments	`AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax`	$-411.00K	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$3.78B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$3.24B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$5.72B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$6.36B	USD	Point-in-time

Income Statement 28 line items

Line Item	Tag	Value	Unit	Period
Net sales	`SalesRevenueNet`	$2.32B	USD	2 Qtrs
Net sales	`SalesRevenueNet`	$1.18B	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$600.04M	USD	2 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$305.54M	USD	1 Quarter
Gross profit	`GrossProfit`	$878.87M	USD	1 Quarter
Gross profit	`GrossProfit`	$1.72B	USD	2 Qtrs
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$431.17M	USD	1 Quarter
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$848.84M	USD	2 Qtrs
Research and development expense	`ResearchAndDevelopmentExpense`	$143.05M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$282.40M	USD	2 Qtrs
Operating profit	`OperatingIncomeLoss`	$304.65M	USD	1 Quarter
Operating profit	`OperatingIncomeLoss`	$586.92M	USD	2 Qtrs
Other income (expense), net	`NonoperatingIncomeExpense`	$-12.27M	USD	2 Qtrs
Other income (expense), net	`NonoperatingIncomeExpense`	$-4.96M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$299.69M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$574.65M	USD	2 Qtrs
Income tax expense	`CurrentIncomeTaxExpenseBenefit`	$154.00M	USD	2 Qtrs
Income tax expense	`CurrentIncomeTaxExpenseBenefit`	$80.32M	USD	1 Quarter
Net earnings	`NetIncomeLoss`	$219.37M	USD	1 Quarter
Net earnings	`NetIncomeLoss`	$420.64M	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$0.63	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$1.21	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.63	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$1.20	USD	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	346.77M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	346.31M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	350.62M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	350.21M	shares	2 Qtrs

Cash Flow Statement 30 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`NetIncomeLoss`	$219.37M	USD	1 Quarter
Net earnings	`NetIncomeLoss`	$420.64M	USD	2 Qtrs
Depreciation	`Depreciation`	$71.41M	USD	2 Qtrs
Amortization	`AdjustmentForAmortization`	$29.53M	USD	2 Qtrs
Amortization of discount on convertible debentures	`AmortizationOfDebtDiscountPremium`	-	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$27.98M	USD	2 Qtrs
Excess tax benefits from stock-based compensation	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$-12.87M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$13.41M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-68.78M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-64.86M	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$-41.36M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-34.08M	USD	2 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$17.43M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$358.46M	USD	2 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$158.48M	USD	2 Qtrs
Business acquisition payments, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$9.06M	USD	2 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-1.33M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-166.21M	USD	2 Qtrs
Proceeds from exercise of stock options and stock issued	`ProceedsFromStockOptionsExercised`	$39.59M	USD	2 Qtrs
Excess tax benefits from stock-based compensation	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$12.87M	USD	2 Qtrs
Common stock repurchased, including related costs	`PaymentsForRepurchaseOfCommonStock`	-	USD	2 Qtrs
Borrowings under debt facilities	`ProceedsFromIssuanceOfLongTermDebt`	$6.69B	USD	2 Qtrs
Payments under debt facilities	`RepaymentsOfLongTermDebt`	$6.58B	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$155.68M	USD	2 Qtrs
Effect of currency exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$2.20M	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$350.13M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$486.57M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$136.44M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$486.57M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$136.44M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.